COCP
Price
$1.54
Change
-$0.03 (-1.91%)
Updated
Aug 29, 02:44 PM (EDT)
Capitalization
16.11M
SGMO
Price
$0.52
Change
-$0.02 (-3.70%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
163.32M
62 days until earnings call
Interact to see
Advertisement

COCP vs SGMO

Header iconCOCP vs SGMO Comparison
Open Charts COCP vs SGMOBanner chart's image
Cocrystal Pharma
Price$1.54
Change-$0.03 (-1.91%)
Volume$100
Capitalization16.11M
Sangamo Therapeutics
Price$0.52
Change-$0.02 (-3.70%)
Volume$57.44K
Capitalization163.32M
COCP vs SGMO Comparison Chart in %
Loading...
COCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COCP vs. SGMO commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COCP is a Hold and SGMO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (COCP: $1.57 vs. SGMO: $0.54)
Brand notoriety: COCP and SGMO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COCP: 19% vs. SGMO: 34%
Market capitalization -- COCP: $16.11M vs. SGMO: $163.32M
COCP [@Biotechnology] is valued at $16.11M. SGMO’s [@Biotechnology] market capitalization is $163.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COCP’s FA Score shows that 0 FA rating(s) are green whileSGMO’s FA Score has 0 green FA rating(s).

  • COCP’s FA Score: 0 green, 5 red.
  • SGMO’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMO is a better buy in the long-term than COCP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COCP’s TA Score shows that 3 TA indicator(s) are bullish while SGMO’s TA Score has 7 bullish TA indicator(s).

  • COCP’s TA Score: 3 bullish, 7 bearish.
  • SGMO’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, SGMO is a better buy in the short-term than COCP.

Price Growth

COCP (@Biotechnology) experienced а +4.19% price change this week, while SGMO (@Biotechnology) price change was -5.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

SGMO is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGMO($163M) has a higher market cap than COCP($16.1M). COCP YTD gains are higher at: -22.277 vs. SGMO (-46.931). COCP has higher annual earnings (EBITDA): -12.3M vs. SGMO (-54.76M). SGMO has more cash in the bank: 38.3M vs. COCP (4.77M). COCP has less debt than SGMO: COCP (1.66M) vs SGMO (23.5M). SGMO has higher revenues than COCP: SGMO (81.7M) vs COCP (0).
COCPSGMOCOCP / SGMO
Capitalization16.1M163M10%
EBITDA-12.3M-54.76M22%
Gain YTD-22.277-46.93147%
P/E RatioN/AN/A-
Revenue081.7M-
Total Cash4.77M38.3M12%
Total Debt1.66M23.5M7%
FUNDAMENTALS RATINGS
COCP vs SGMO: Fundamental Ratings
COCP
SGMO
OUTLOOK RATING
1..100
898
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
7964
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGMO's Valuation (55) in the Biotechnology industry is in the same range as COCP (66) in the Pharmaceuticals Generic industry. This means that SGMO’s stock grew similarly to COCP’s over the last 12 months.

SGMO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as COCP (100) in the Pharmaceuticals Generic industry. This means that SGMO’s stock grew similarly to COCP’s over the last 12 months.

SGMO's SMR Rating (100) in the Biotechnology industry is in the same range as COCP (100) in the Pharmaceuticals Generic industry. This means that SGMO’s stock grew similarly to COCP’s over the last 12 months.

SGMO's Price Growth Rating (64) in the Biotechnology industry is in the same range as COCP (79) in the Pharmaceuticals Generic industry. This means that SGMO’s stock grew similarly to COCP’s over the last 12 months.

SGMO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as COCP (100) in the Pharmaceuticals Generic industry. This means that SGMO’s stock grew similarly to COCP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COCPSGMO
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
COCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFG5.180.86
+19.91%
Uni-Fuels Holdings Ltd
BGI0.810.09
+11.86%
Birks Group
UI532.297.98
+1.52%
Ubiquiti
IPAR116.530.51
+0.44%
Interparfums Inc
AVBP19.21N/A
N/A
ArriVent BioPharma

COCP and

Correlation & Price change

A.I.dvisor indicates that over the last year, COCP has been loosely correlated with FATE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if COCP jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COCP
1D Price
Change %
COCP100%
+1.29%
FATE - COCP
34%
Loosely correlated
-3.57%
SGMO - COCP
33%
Loosely correlated
+0.54%
VKTX - COCP
31%
Poorly correlated
+3.61%
BYSI - COCP
28%
Poorly correlated
-1.10%
CYTK - COCP
27%
Poorly correlated
-1.27%
More